Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Primary bone tumours

Oncology and palliative care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Pathological fracture, cord compression or acute neurovascular compromise

A fracture through an unexplained destructive lesion, rapidly progressive weakness or sphincter dysfunction from vertebral disease, or threatened limb perfusion requires immediate stabilisation without contaminating future tumour planes.

Action: Immobilise and provide analgesia, document distal neurovascular status, obtain urgent radiographs and specialist cross-sectional imaging and contact the bone-sarcoma centre before biopsy, internal fixation or curettage. Manage suspected cord compression with the metastatic-spinal-cord-compression pathway and plan any operation so the biopsy tract and contaminated tissue can be removed en bloc.

Synopsis

Recognise a possible primary malignant bone tumour before fracture or unplanned surgery, complete compartment-aware imaging, obtain a sarcoma-centre-planned biopsy and coordinate histology-specific chemotherapy, wide resection, radiotherapy, reconstruction and survivorship care.

  • Primary malignant bone tumours are rare; osteosarcoma peaks in adolescents, Ewing sarcoma in children and young adults, and conventional chondrosarcoma in later adulthood.
  • Persistent night or rest pain, focal swelling and an unexplained pathological fracture are key warning features; a remembered sports injury does not exclude sarcoma.
  • First-line imaging is a high-quality plain radiograph in two planes including the whole involved bone and adjacent joints.
  • MRI of the entire involved bone and compartment is the preferred local-staging test and must be completed before biopsy where practical.
  • CT chest is the standard first staging test for pulmonary metastases; bone scintigraphy or PET-based imaging assesses additional skeletal disease according to histology and protocol.
  • The diagnostic reference standard is image-guided core biopsy planned by the bone-sarcoma MDT so its tract can be removed with the definitive specimen.
  • Never perform unplanned curettage, excision or routine internal fixation of a suspicious lesion; contamination can convert a limb-sparing resection into a larger operation or amputation.
  • Osteosarcoma treatment usually combines multiagent chemotherapy with wide surgical resection; response is assessed by necrosis in the resection specimen.
  • Ewing sarcoma requires systemic multiagent chemotherapy plus surgery and or radiotherapy for local control; treatment of all metastatic sites is considered in curative protocols.
  • Conventional chondrosarcoma is managed mainly by complete wide resection because ordinary chemotherapy and radiotherapy have limited activity; mesenchymal and dedifferentiated subtypes differ.
  • A pathological fracture is immobilised and discussed with the sarcoma surgeon before any fixation; the definitive construct must be part of the oncological resection plan.
  • Limb salvage is preferred when a wide margin and useful function are achievable, but amputation may provide the safest margin or best function in selected cases.
  • Follow-up concentrates on lung relapse, local recurrence, reconstruction performance and lifelong cardiotoxic, renal, auditory, fertility and second-cancer effects.

Key red flags

Persistent focal bone pain, especially pain at night or at rest, warrants imaging when it is progressive, localised or unexplained by a resolving injury.

A firm enlarging swelling fixed to bone, reduced adjacent-joint movement or focal warmth requires urgent radiography and specialist review.

A fracture after trivial force through a lytic, mixed or sclerotic lesion is pathological until proved otherwise and must not undergo routine fixation before tumour planning.

A child or young adult with metaphyseal pain and swelling around the knee or shoulder may have osteosarcoma even when symptoms began after sport.

Fever, weight loss and diaphyseal pain can mimic infection but may indicate Ewing sarcoma; neither antibiotics nor drainage should precede adequate imaging and tissue when stable.

Back pain with weakness, sensory change, gait loss or bladder or bowel dysfunction requires emergency spinal imaging and specialist decompression assessment.

A destructive bone lesion in a patient older than 40 is more likely metastasis or myeloma than primary sarcoma, but tissue strategy still matters when the diagnosis is uncertain.

Pathological fracture

Sudden inability to bear weight through a destructive lesion is an oncological emergency requiring immobilisation and sarcoma-centre planning before fixation.

Investigation priorities

01
First-line whole-bone radiographsFirst stepFirst line

Characterise matrix, margins, periosteal reaction, cortical integrity and fracture in two planes including both adjacent joints.

02
Preferred MRI for local stagingPreferred

Map full intramedullary length, skip lesions, soft-tissue extension, joint involvement and relationship to nerves and vessels before biopsy.

Management branches

Suspicious bone lesionImage before tissue and refer before intervention

Persistent focal bone symptoms or radiography shows an aggressive or unexplained lesion.

  1. Obtain two-plane radiographs of the whole bone, examine swelling, joint and neurovascular function and provide safe analgesia and weight-bearing advice.
  2. Contact the regional bone-sarcoma service and complete tumour-protocol MRI before biopsy, with CT chest and whole-body staging arranged through the specialist team.
  3. Use MDT-planned image-guided core biopsy with a resectable tract, then integrate expert pathology, molecular results and stage before any definitive operation.

Key medicines

MAP chemotherapy for osteosarcomaUse specialist-protocol high-dose methotrexate with folinic-acid rescue, doxorubicin and cisplatin in suitable younger patients; exact doses, cycles, hydration and rescue are determined by the national age-specific sarcoma protocol.Monitor methotrexate clearance, renal and liver function, mucositis, marrow, infection, cisplatin hearing and kidney injury and cumulative anthracycline cardiac exposure; delayed clearance is an emergency.
VDC/IE chemotherapy for Ewing sarcomaAlternate specialist cycles of vincristine, doxorubicin and cyclophosphamide with ifosfamide and etoposide at protocol-defined intervals, using mesna, hydration and growth-factor support as specified.Watch febrile neutropenia, haemorrhagic cystitis, ifosfamide encephalopathy and renal tubular injury, neuropathy, infertility, secondary leukaemia and lifetime anthracycline dose.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • UK guidelines for the management of bone sarcomasReferral, imaging, biopsy planning, pathology, staging, treatment and follow-up.
  • NICE NG12 bone sarcoma referral recommendationsUrgent radiography and referral for suspicious bone symptoms and imaging.
  • NCI osteosarcoma and undifferentiated pleomorphic sarcoma PDQOsteosarcoma systemic treatment, surgery, metastatic disease and prognostic context.
  • NCI Ewing sarcoma treatment PDQEwing diagnosis, chemotherapy, local control and metastatic treatment evidence.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Spinal or pelvic compromise

Weakness, sphincter change, radicular pain, hydronephrosis or vascular swelling may reflect a bulky tumour threatening cord, roots or pelvic organs.